There are between 140 and 580 million IBS sufferers, many undiagnosed, and within this group more than 220 million young women in need of nutritional support for IBS symptoms. A growing body of research backs probiotic and synbiotic supplements to offer real benefits to hundreds of millions of Irritable Bowel Syndrome (IBS) sufferers globally. This report examines online retailing, regulatory, marketing as well as scientific data and trends in 20 countries to pry open a niche but expanding sector bristling with business opportunity.
- There are between 140 and 580 million IBS sufferers, many undiagnosed, and there is a pool of 220 million young women in need of nutritional support for IBS symptoms.
- Direct and indirect costs to society include reduction of physical activity, lost work productivity and absenteeism, increased prevalence of anxiety and mood disorders, as well as social stigmas and societal alienation.
- The difficulty in diagnosing IBS is a global challenge. The devastating effect IBS has on people’s lives could be significantly reduced with more rapid, accurate diagnosis and treatment. The Internet is key to speeding up this process.
- Although not conclusive, a significant body of research has found that single and multiple strain probiotic supplementation, as well as synbiotic supplementation, can be effective in offering relief for most IBS symptoms.
- 11 of the surveyed countries feature IBS-positioned probiotic supplements, with none in big markets like the US, Brazil, nor mainland China.
Report preview: Page 28 of 46
- Global picture
- Country & strain focus
- North America
- South Africa
- IBS claims and science
- Appendix of studies
How to access this report
This report is available to subscribers of Lumina Intelligence Probiotics. To hear more about Lumina Intelligence Probiotic, and for subscription enquiries, please contact our team on +44(0)1293 846 699 or by email at email@example.com. To request a demonstration of Lumina Intelligence Probiotics, please fill out a request a demo form.